Immunscape develops small molecules to treat immune diseases and harness the immune system to fight cancer.

Immunscape is a privately-held drug discovery company based in Stockholm, Sweden. Founded in 2016, Immunscape is focused on the development of immunotherapies for the treatment of cancer and autoimmune diseases. Immunscape has a team with a proven track record of success in bringing small molecules from discovery phase to the clinic.